|
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-14 00:00:00 |
| Sponsor | MedPacto, Inc.;145 Gwanggyo-ro, Advanced Institutes of Convergence Technology;Suwon |
